Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D[sub.3] and Respond to 24R,25-dihydroxyvitamin...
Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D[sub.3] and Respond to 24R,25-dihydroxyvitamin D[sub.3] via a Mechanism Dependent on Estrogen Receptor Levels
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
Vitamin D supplementation’s effectiveness in reducing cancer is widely debated. The controversy may be explained by differences in 25(OH)D[sub.3] metabolism. Previous studies showed that breast cancer cells produce vitamin D[sub.3] metabolites locally, and their ability to regulate tumorigenesis is related to the presence of estrogen receptor alpha...
Alternative Titles
Full title
Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D[sub.3] and Respond to 24R,25-dihydroxyvitamin D[sub.3] via a Mechanism Dependent on Estrogen Receptor Levels
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A793567041
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A793567041
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers16091635
